Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria

Clinical trial NCT00616304 · SUSPENDED

Trial details

NCT number: NCT00616304
Sponsor: Menzies School of Health Research
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Falciparum Malaria

Start date: 2008-02-01
Primary completion: 2009-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.